| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |